Neurofibroma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{SC}} | {{CMG}}; {{AE}} {{SC}} | ||
==Overview== | ==Overview== | ||
[[Immunohistochemistry]] of [[neurofibroma]] shows [[Positivity effect|positivity]] for [[S100A1|S100]], [[CD34]], and factor XIIIa and [[Negativity bias|negativity]] for EMA (except in [[Plexiform neurofibroma|plexiform neurofibromas]]). | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
Immunohistochemistry of neurofibroma is as follows: | [[Immunohistochemistry]] of [[neurofibroma]] is as follows: | ||
*Positive for: | *Positive for: | ||
**S100 | **[[S100A1|S100]] | ||
**CD34 (focal) | **[[CD34]] (focal) | ||
**Factor XIIIa (focal) | **Factor XIIIa (focal) | ||
*Negative for: | *Negative for: | ||
**EMA (except in plexiform neurofibromas) | **EMA (except in [[Plexiform neurofibroma|plexiform neurofibromas]]) | ||
==References== | ==References== | ||
Revision as of 15:31, 25 March 2019
|
Neurofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neurofibroma laboratory findings On the Web |
|
American Roentgen Ray Society Images of Neurofibroma laboratory findings |
|
Risk calculators and risk factors for Neurofibroma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Immunohistochemistry of neurofibroma shows positivity for S100, CD34, and factor XIIIa and negativity for EMA (except in plexiform neurofibromas).
Laboratory Findings
Immunohistochemistry of neurofibroma is as follows:
- Positive for:
- Negative for:
- EMA (except in plexiform neurofibromas)